Association between human μ-opioid receptor gene polymorphism, pain tolerance, and opioid addiction

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 121 B, Issue 1, 2003, Pages 76-82

  Compton, Peggy ^a   Geschwind, Daniel H ^b   Alarcón, Maricela ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A118G; C17T; Hyperalgesia

Indexed keywords

METHADONE; MU OPIATE RECEPTOR; OPIATE;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNOLOGY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MICROSATELLITE MARKER; NOCICEPTIVE STIMULATION; NUCLEOTIDE SEQUENCE; OPIATE ADDICTION; PAIN THRESHOLD; PILOT STUDY; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REWARD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0041318947     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20057     Document Type: Article

References (75)

1. American Pain Society. 2002. Promoting pain relief and preventing abuse of pain medications: A critical balancing act. http://www.ampainsoc.org/advocacy/promoting.htm
2. Antonaci F, Sand T, Lucas GA. 1998. Pressure algometry in healthy subjects: Inter-examiner variability. Scand J Rehab Med 30:3-8.
3. Belknap JK, Mogil JS, Helms ML, Richards SP, O'Toole LA, Bergeson SE, Buck KJ. 1995. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA strains. Pharm Let 57:117-124.
4. Berrettini WH, Alexander R, Ferraro TN, Vogel WH. 1994. A study of oral morphine preference in inbred mouse strains. Psychia Genetics 4:81-86.
5. Berrettini WH, Hoehe MR, Ferraro TN, DeMaria PA, Gottheil E. 1997. Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict Biol 2:303, 308.
6. Blitz B, Dennestein AJ. 1968. Pain attenuation by contralateral cold stimulation. Psychon Sci 10:395-396.
7. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schuluger J, Strong J, Leal S, Tischfield J, Kreek MJ, Yu L. 1998. Single-nucleotide polymorphism in the human mu opioid receptor gene alters B-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci USA 94:9608-9613.
8. Celerier E, Laulin JP, Corcuff JB, Le Moal M, Simonnet G. 2001. Progerssive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization precess. J Neurosci 21(11):4074-4080.
9. Celerier E, Laulin JP, Larcher A, Le Moal M, Simonnet G. 1999. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res 847:18-25.
10. Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simmonet G. 2000. Long-lasting hypetalgesia induced by fetanyl in riats. Anesthesiology 92(2):465-472.
11. Chen ACN, Dworkin SF, Haug J, Gehrig J. 1989. Human pain responsivity in a tonic pain model: Psychological determinants. Pain 37:143-160.
12. Cheru-Croze S. 1983. Relationship between noxious cold stimuli and the magnitude of pain sensation in man. Pain 15:265-269.
13. Chipps L, Compton P. 2001. Concurrent Validity of Pressure Algometry. Paper presentation, St. Louis University Alpha Omega Alpha Medical Student Research Forum, April.
14. Colpaert F. 1996. System theory of pain and of opiate analegesia: No tolerance to opiates. Pharmacol Rev 48:355-402.
15. Compton M. 1994. Cold pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status. J Pain Symptom Manage 9:462-473.
16. Compton P, Charuvastra C, Kintaudi K, Ling W. 2000. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage 20:237-245.
17. Compton P, Charuvastra VC, Ling W. 2001. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug Alcohol Depend 63:139-146.
18. Doverty M, White J, Somogyi A, Bochner F, Ali R, Ling W. 2001a. Hyperalgesic responses in methadone maintained patients. Pain 90:91-96.
19. Doverty M, Somogyi AA, White JM, Bochner F, Beare CH, Melelaou A, Ling W. 2001b. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 93:155-163.
20. Dundee JW, Moore J. 1960. Alterations in response to somatic pain associated with anaesthesia. I: An evaluation of a method on analgesimetry. Br JAnaes 32:396-405.
21. Eidelberg E, Erspamer R, Kreinick CJ, Harris J. 1975. Genetically determined differences in the effects of morphine on mice. Eur J Pharmacol 32:329-336.
22. Elmer GI, Pieper JO, Goldberg SR, George FR. 1995. Opioid operant self-administration, analgesia, stimulation and respiratory depression in μ-deficient mice. Psychopharm 117:23-31.
23. Elmer GI, Pieper JO, Negus SS, Woods JH. 1998. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75:129-140.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press, Inc.
25. Franke P, Wang T, Nothen M, Knapp M, Neidt H, Albrecht S, Jahnes E, Propping P, Maier W. 2001. Nonreplication of association between μ-opioid-receptor gene (OPPM1) A118G polymorphisms and substance dependence. Am J Genet (Neuropsychiatr Genet) 105:114-119.
26. Garcia de Jalon PD, Harrison FJJ, Johnson KI, Kozma C, Schnelle K. 1985. A modified cold-stimulation technique for the evaluation of analgesic activity in human volunteers. Pain 22:183-189.
27. Gelernter J, Kranzler H, Lacobelle J. 1998. Population studies of polymorphisms at loci of neuropsychiatric interest (Tryptophan Hydroxylase (THP), Dopamine transporter protein (SLC6A3), D3 Dopamine receptor (DRD3), Apolipoprotein E (APOE), μ Opioid receptor (OPRM1), and Ciliary neurotrophic factor (CNTF)). Genomics 52:289-297.
28. Gelernter J, Kranzler H, Cubells J. 1999. Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: Population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry 4:476-483.
29. Gscheidel N, Sander T, Wendel B, Heere P, Schmidt LG, Rommelspacher H, Hoehe MR, Samochowiec J. 2000. Five exon 1 variants of mu opioid receptor and vulnerability to alcohol dependence. Pol J Pharmacol 52:27-31.
30. Ho A, Dole VP. 1979. Pain perception in drug-free and in methadone-maintained human ex-addicts. Proc Society Exp Biol Med 162:392-395.
31. Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK, Berrettini WH, Church GM. 2000. Sequence variability and candidate gene analysis in complex disease: Association of μ-opiod receptor gene variation with substance dependence. Hum Mol Genet 9:2895-2908.
32. Holt J, Mao J, Mayer D, Price D. 1999. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA 96:7731-7736.
33. Jensen K, Andersen HO, Olesen J, Lindblom U. 1986. Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain 25:313-323.
34. Kranzler HR, Gelernter J, O'Malley S, Hernandez-Avila CA, Kaufman D. 1998. Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). Alcoholism 22:1359-1362.
35. Laulin JP, Celerier E, Larcher A, Le Moal M, Simmonet G. 1999. Opiate tolerance to daily heroin administration: An apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89(3):631-636.
36. Liebmann P, Lehofer M, Moser M, Hoehn-Saric R, Legl T, Pernhaupt G, Schauenstein K. 1997. Persistent analgesia in former opiate addicts is resistant to blockade of endogenous opioids. Biol Psychiatry 42:962-964.
37. Liebmann P, Lehofer M, Moser M, Legl T, Pernhaupt G, Schauenstein K. 1998. Nervousness and pain sensitivity: II. Changed relation in exaddicts as a predictor for early relapse. Psychiatry Res 79:55-58.
38. Longo LP, Parran T, Johnson B, Kinsey W. 2000. Addiction: Part II. Identification and management of the drug-seeking patient. Am Fam Physician 61:2401-2408.
39. Lotsch J, Skarke C, Grosch S, Darimont J, Schmidt H, Geisslinger G. 2002. The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 12(1):3-9.
40. Mao J, Price D, Mayer D. 1994. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C. J Neurosci 14(4):2301-2312.
41. Mao J, Price D, Mayer D. 1995a. Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61:353-364.
42. Mao J, Price D, Mayer D. 1995b. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain 62:259-274.
43. Mao J, Price D, Phillips L, Lu J, Mayer D. 1995c. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res 677:257-267.
44. Matthes J, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques B, Kieffer BL. 1996. Loss of morphine induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383:819-823.
45. Mayer P, Holtt V. 2001. Allelic and somatic variations in the endogenous opioid system of humans. Pharmacol Ther 91:167-177.
46. Mayer D, Mao J, Price D. 1995a. The association of neuropathic pain, morphine tolerance and dependence, and the translocation of protein kinase C. NIDA Res Mon 147:269-298.
47. Mayer D, Mao J, Price D. 1995b. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61:365-374.
48. Mayer DJ, Mao J, Holt J, Price DD. 1999. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA 96:7731-7736.
49. Mayer P, Rochlitz H,Rauch E, Rommelspacher H, Hasse HE, Schmidt S. 1997. Association between a delta opioid receptor gene polymorphism and heroin dependence in man. NeuroReport 8:2547-2550.
50. McQuay HJ, Jadad AR, Carroll D, Faura C, Glynn CJ, Moore RA, Lui Y. 1992. Opioid sensitivity of chronic pain: A patient-controlled analgesia method. Anaesthesia 47:757-767.
51. Merskey H, Spear FG. 1964. The reliability of the pressure algometer. Br J Soc Clin Psycho 3:130-136.
52. Mogil JS. 1999. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA 96:7744-7751.
53. Mogil JS, Grisel J. 1998. Transgenic studies of pain. Pain 77:107-128.
54. Mogil JS, Marek P, Flodman P, Spence MA, Sternberg WF, Kest B, Sadowski B, Liebeskind JC. 1995. One or two genetic loci mediate high opiate analgesia in selectively bred mice. Pain 60:125-135.
55. Mogil JS, Sternberg WF, Marek P, Sadowski B, Belknap JK, Liebeskind JC. 1996. The genetics of pain and pain inhibition. Proc Natl Acad Sci USA 93:3048-3055.
56. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain H, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M. 1999a. Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception. Pain 80:67-82.
57. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain H, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M. 1999b. Heritability of nociception II: "Types" of nociception revealed by genetic correlation analysis. Pain 80:83-93.
58. Morgan J. 1986. American opiophobia: Customary underutilization of opioid analgesics. In: Controversies in alcoholism and substance abuse, Vol 5. New York: Haworth. 163-173.
59. Parran T. 1997. Prescription drug abuse: A question of balance. Med Clin North Am 81:967-978.
60. Ramabadran K, Michaud G, Jacob JJC. 1982. Genetic influences on the control of nociceptive responses and precipitated abstinence in mice. Ind J Exp Biol 20:74-76.
61. Reeves JL, Jaeger B, Graff-Radford B. 1986. Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity. Pain 24:313-321.
62. Schall U, Katta T, Pries E, Kloppel A, Gastpar M. 1996. Pain perception of intravenous heroin users on maintenance therapy with levomethadone. Pharmacopsychiatry 29:176-179.
63. Semenova S, Kuzmin A, Zvartau E. 1995. Strain differences in the analgesic and reinforcing action of morphine in mice. Pharmacol Biochem Behav 50:17-21.
64. Shi J, Hui L, Xu Y, Wang F, Huang W, Hu G. 2002. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat DOI 10.1002/humu.9026.
65. Smolka M, Sander T, Sehmidt LG, Samochowiec J, Rommelspacher H, Gscheidel N, Wendel B, Hoehe M. 1999. μ-Opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal. Psychoneuroendocrinology 24:629-638.
66. Szeto C, Tang N, Lee D, Stadlin A. 2001. Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. NeuroReport 12(6):1103-1106.
67. Tassorelli C, Micieli G, Osipova V, Rossi F, Nappi G. 1995. Pupillary and cardiovascular responses to the cold-pressor test. J Auton Nerv Syst 55:45-49.
68. Town T, Abdullah L, Crawford F, Schinka J, Ordorica PI, Francis E, Hughes P, Duara R, Mullan M. 1999. Association of a functional μ-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet 88:458-461.
69. Uhl GR, Sora I, Wang Z. 1999. The mu opiate receptor as a candidate gene for pain: Polymorphisms, variations in expression, nocioception, and opiate responses. Proc Natl Acad Sci USA 96:7752-7755.
70. Vanderah T, Suenaga N, Ossipov M, Malan T Jr, Lai J, Porreca F. 2001. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 21(1):279-286.
71. Wand G, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A. 2002. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation inducted by opioid receptor blockage. Neuropsychopharmacology 26(1):106-114.
72. Walsh NE, Schoenfeld L, Ramamurthy S, Hoffman J. 1989. Normative model for cold pressor test. Am J Phys Med Rehab 68:6-11.
73. Wolff BB, Kantor TG, Cohen P. 1976. Laboratory pain induction methods for human analgesic assays. In: Bonica JJ, Albe-Fessard D, editors. Advances in pain research and therapeutics, Vol 1. New York: Raven Press. pp 363-367.
74. Wolff B, Kantor TG, Jarvik ME, Laska E. 1969. Responses of experimental pain to analgesic drugs; III. Codeine, aspirin, secobarbital, and placebo. Clin Pharmacol Ther 10:217-228.
75. Woodrow KM, Friedman GD, Siegelaub AB, Collen MF. 1972. Pain tolerance: Differences according to age, sex and race. Psychosom Med 34:548-556.